A large body of evidence suggests that hyperinsulinemia is a common feature shared by obesity, high-blood pressure (HBP), and type 2 diabetes. [1] [2] [3] [4] Given that hyperinsulinemia is more frequent in subjects with a family history of hypertension (FHH) than in those with a negative family history of hypertension (NFH), heredity appears to play a relevant role in the development of metabolic abnormalities. 5 Young normotensive individuals with FHH have hyperinsulinemia, impaired insulin-mediated glucose uptake, and dyslipidemia compared to matched individuals with NFH, 6-10 findings that suggest an underlying genetic cause of metabolic disorders.
A large body of evidence suggests that hyperinsulinemia is a common feature shared by obesity, high-blood pressure (HBP), and type 2 diabetes. [1] [2] [3] [4] Given that hyperinsulinemia is more frequent in subjects with a family history of hypertension (FHH) than in those with a negative family history of hypertension (NFH), heredity appears to play a relevant role in the development of metabolic abnormalities. 5 Young normotensive individuals with FHH have hyperinsulinemia, impaired insulin-mediated glucose uptake, and dyslipidemia compared to matched individuals with NFH, [6] [7] [8] [9] [10] findings that suggest an underlying genetic cause of metabolic disorders.
In addition, it has been reported that FHH is linked to increased systolic and diastolic BP in the offspring of hypertensive subjects. [11] [12] [13] The Hypertension in Pregnancy Offspring Study showed that mothers with gestational hypertension and with sustained postpartum hypertension (for 7-12 years following birth) have hypertensive children at greater frequency than mothers with gestational hypertension but no postpartum hypertension. 14 These findings strongly suggest that cardiovascular risk factors (CVRFs) could emerge before adolescence in offspring of hypertensive subjects. Data associating FHH with the development of metabolic abnormalities and HBP have been largely obtained in adolescents and adults. Because such studies in young children are scarce and generally have small sample sizes, we tested the hypothesis that FHH is related to CVRFs in healthy prepubertal children.
Methods
This protocol was approved by the Ethics Committees of the Faculty of Medicine of the University of San Luis Potosi (San Luis Potosi, Mexico), and the Mexican Social Security Institute (Durango, Mexico). Informed consent was obtained from the children and their parents in a community-based cross-sectional population study.
The sampling strategy was based on a two-stage random sample. The first stage included a random selection of elementary Background To determine the relationship between family history of hypertension (Fhh) and cardiovascular risk factors (cVRF) in healthy prepubertal children. The sample size was estimated to enable detection of differences in HBP equal to or >3%, based on an α-level of 5% and a confidence interval (CI) of 95%.

Design
Before study enrollment, a detailed medical history and complete physical examination were performed to verify that all the participants were in good health. Children with positive family history of diabetes in their first-degree relatives, with diagnosis of acute or chronic illnesses, or undergoing any kind of medical treatment were excluded. Eligible healthy boys and girls aged 6-10 years in Tanner stage 1, 15 were allocated into groups with and without FHH.
Definitions. FHH was defined by the presence of hypertension in at least one parent of the enrolled children. FHH was ascertained by a self-administered questionnaire to the parents and by verification of clinical records. FHH was stratified according its presence in the maternal branch, parental branch, and in both parents to compare each category to the reference of children with NFH.
In agreement with the criteria adopted by Cook et al. 16 for defining metabolic syndrome in children, the following CVRFs were studied: elevated waist circumference (WC) defined as WC ≥90th percentile according age and sex; HBP defined as systolic and/or diastolic BP ≥90th percentile for height and sex; hyperglycemia defined as fasting plasma glucose (FPG) levels ≥110 mg/ dl, hypertriglyceridemia defined as triglycerides levels ≥110 mg/dl, and low high-density lipoprotein (HDL)-cholesterol defined as serum levels ≤40 mg/dl. Metabolic syndrome was defined as the presence of at least three of the abovementioned features. Hyperinsulinemia was defined as fasting serum insulin levels ≥15 µU/ml. 17 References tables for WC and BP were the tables from the National Health and Nutrition Examination Survey 1999-2004, 18 and the tables from the National HighBlood Pressure Education Program Working Group on highblood pressure in children and adolescents. 19 Measurements. WC was measured to the nearest centimeter with a flexible steel tape while the subjects were in standing position. The two anatomical landmarks used to determine tape placement were midway between the lowest portion of the rib cage and the superior border of the iliac crest (laterally) and the umbilicus (anteriorly). 20, 21 If the lateral and anterior landmarks did not align, the lateral landmark was used. The investigators confirmed that the tape was parallel to the floor and was snug without compressing the skin.
All measurements were performed in fasting conditions between 8.00 and 9.00 am, with the subjects in standing position wearing light clothing and without shoes.
BP measurements were taken with the subjects seated and their arms bared and supported at heart level, after at least 5 min of rest, and with an appropriate cuff size. 22 Data were collected as the average of three readings, each separated by 2 min.
Assays.
A venous whole blood sample was collected after an overnight fast (8-10 h of fasting). Plasma glucose concentrations were determined using the glucose-oxidase method (Sigma Diagnostics, St Louis, MO), with intra-and interassay variation coefficients of 2.4 and 3.8%, respectively.
Triglycerides were measured enzymatically. HDL-cholesterol fraction was obtained after precipitation by phosphotungstic reagent. The intra-and interassay coefficients of variation were 1.9 and 3.7% for triglycerides, and 1.5 and 3.1% for HDLcholesterol.
Insulin levels were measured by microparticle enzyme immunoassay (Abbot Axsym System, Chicago, IL) with intraand interassay variation coefficients of 4.1 and 6.2%.
Samples were frozen and stored at -20 °C until further analysis. All measurements were performed in a Data Pro Plus random access clinical analyzer (Arlington, TX).
Statistical analysis.
Numerical values are reported as mean ± s.d., and categorical variables are expressed as proportions.
For bivariate analysis, Student's t-test (or alternately MannWhitney U-test for skewed data) and χ 2 -test were used for numerical and categorical data, respectively.
Differences between more than two groups were analyzed using one-way ANOVA with Bonferroni post hoc t-tests.
A multivariate logistic regression analysis was performed in successive steps to estimate the association between FHH (independent variable) and CVRFs (dependent variables). In the first step, the odds ratio (OR) between FHH and CVRFs was evaluated in the entire study population. In the second step, the study population was stratified by WC, given that excess visceral abdominal obesity is a recognized independent contributor to several metabolic abnormalities and to cardiovascular risk. 16 A P value <0.05 or 95% CI (CI 95% ) defined statistical significance. Data were analyzed by using the statistical package SPSS for Windows 15.0 (IBM Company, Chicago, IL).
results
A total of 358 children, 192 (53.6%) girls and 166 (46.4%) boys, with average age of 8.2 ± 1.2 years were included.
FHH was identified in 72 (20.1%) children; of these, 45 (62.5%) had FHH in the maternal branch, 16 (22.2%) in the paternal branch, and 11 (15.3%) in both parents.
A total of 212 (59.2%) children had at least one CVRF, where low HDL-cholesterol levels (36.3%), elevated WC (29.3%), and hypertriglyceridemia (28.8%) were the most frequent. HBP and hyperglycemia were recognized in 10 (3.4%) and 1 (0.3%) children, respectively. Metabolic syndrome and hyperinsulinemia were identified in 36 (10.1%) and 48 (13.4%) children. Table 1 shows the characteristics of the children with and without FHH. FPG and insulin levels were significantly higher in the children with FHH in the maternal branch; other variables original contributions
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were not significantly different from that of the children with FHH in the paternal branch, FHH in both parents, or NFH. Figure 1 shows the proportion of CVRFs in children with FHH and NFH; prevalence of CVRFs was higher in children with FHH in the maternal branch.
The interaction of elevated WC with FHH contributed for dyslipidemia (63.6%), metabolic syndrome (45.5%), and HBP (13.6%). On the other hand, the interaction of nonelevated WC with FHH contributed for dyslipidemia (84%), metabolic syndrome (98%), HBP (96%), and hyperglycemia (100%).
After stratification by WC, children with nonelevated WC and with FHH in the maternal branch had significantly elevated insulin and FPG as compared with groups with FHH in paternal branch, and NFH. In addition, children with FHH in both parents also showed higher insulin levels than children in the NFH group. Other variables showed no significant differences between the groups ( Table 2) .
In all children, FHH was significantly associated with hyperinsulinemia (OR 2.0; 95% CI 1.2-8.4), but not to other CVRFs. Subsequent analysis stratified by WC showed that FHH in the maternal branch was associated with hyperinsulinemia, HBP, hypertriglyceridemia, and low HDL-cholesterol in the children with nonelevated WC, but not in the children with elevated WC (Table 3) .
discussion
In this study, the frequency of CVRFs in the children with FHH in the maternal branch was higher than the frequency in children with FHH in the paternal branch and in those with NFH.
In addition, in children with nonelevated WC, FHH in maternal branch was associated with HBP, hyperglycemia, hypertriglyceridemia, and low HDL-cholesterol. Among children with elevated WC, the present study also showed that the frequency of CVRFs is elevated and similarly distributed in the children with and without FHH, and that FHH was not independently associated with CVRFs.
Interestingly, although the proportion of children with HBP was significantly higher in those with FHH in the maternal branch and in both parents, the mean ± s.d. of HBP was similar in all the analyzed subgroups ( Table 1) , which was not related to differences in WC ( Table 2 ). This apparent discrepancy could be explained by the fact that only 10 children exhibited HBP, taking into account that the hypertensive children were dispersed into the different subgroups (Figure 1 ) and the large sample size. As such, it is likely that the mean HBP within each subgroup was not significantly modified by this small sample.
A large body of evidence shows that multiple CVRFs cooccur to a greater degree than would be expected in subjects with high-insulin levels. [23] [24] [25] Our study shows that irrespective of elevated WC, healthy prepubertal children with FHH in the maternal branch have significantly higher insulin levels than children with family history in the paternal branch and in ANOVA, analysis of variance; HDL-cholesterol, high-density lipoprotein-cholesterol. a P value estimated using one-way ANOVA test (skewed data were log transformed to normalize distribution). b P value intergroups. c P value, between the group with negative family history and the group with family history in the maternal branch, estimated using Bonferroni post hoc test. The prevalence of cardiovascular risk factors was significantly higher in the group with family history of hypertension in the maternal branch; on the other hand, the frequency of cardiovascular risk factors does not significantly differ between the groups with family history in the paternal branch, in both parents, and negative family history of hypertension. hBP, high-blood pressure; hG, hyperglycemia; hI, hyperinsulinemia; hT, hypertriglyceridemia; L-hDL, low high-density lipoprotein-cholesterol; MetS, metabolic syndrome. *P < 0.01, compared with group with negative family history of hypertension.
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Family Hypertension and Cardiovascular Risk those with NFH, suggesting that hyperinsulinemia could be the primary metabolic alteration in the offspring of hypertensive mothers. Furthermore, in the children with nonelevated WC, FHH in the maternal branch was significantly associated with hyperinsulinemia and other CVRFs. In addition, we observed one subject with hyperglycemia in this subgroup. These findings suggest that the history of maternal hypertension indicates greater cardiovascular risk in children. [26] [27] [28] [29] [30] Furthermore, these findings support the hypothesis that cardiovascular risk phenotype is transmitted on the maternal lineage with a pattern that indicates mitochondrial DNA-mediated inheritance. Although a body of evidence has accumulated in this regard, further research is needed to give new insight to the genetic etiology of cardiovascular risk in children. Among the children with elevated WC, the well-known positive correlation between adiposity and hyperinsulinemia 31 ANOVA, analysis of variance; HDL-cholesterol, high-density lipoprotein-cholesterol. a P value estimated using one-way ANOVA test (skewed data were log transformed to normalize distribution). b P value intergroups. c P value, between the group with negative family history and the group with family history in the maternal branch, estimated using Bonferroni post hoc test. d Data are median (interquartile range). e P value, between the group with negative family history and the group with family history in both parents, estimated using Bonferroni post hoc test.
Family Hypertension and Cardiovascular Risk could explain the observed hyperinsulinemia and elevated CVRFs, independent of family history.
In addition to elevated WC, other risk factors could be involved in the increased cardiovascular risk. Among these, elevated serum uric acid is an independent risk factor for cardiovascular disease, perhaps as a consequence of an impaired vascular nitric oxide activity, 32 supporting the hypothesis that oxidative stress could be the common factor underlying insulin resistance and cardiovascular risk. 33 Furthermore, in the absence of obesity, some nutritional factors may contribute to cardiovascular risk, such as low intake of n-3 polyunsaturated fatty acids 34 and increased intake of salt. 35 Finally, hypomagnesemia may play a role in increased risk for metabolic syndrome. [36] [37] [38] Through the release of substance P, magnesium depletion may be the earliest pathophysiological event leading to systematic inflammation, endothelial dysfunction, and free radical-mediated injury during the development of cardiovascular disease. 39, 40 This study did not measure uric acid, nutrient intake, or serum magnesium; further research is needed to appropriately establish their effects on the development or cardiovascular risk in early life.
Previous studies from our group have shown that family history of diabetes is independently associated with hyperinsulinemia and dyslipidemia in nonobese Mexican children. [41] [42] [43] As such, the presence of diabetes in first-degree relatives was among our exclusion criteria to control for this possible confounder. To our knowledge, other studies exploring the association between FHH and CVRFs have not controlled for the potential bias of family history of diabetes.
Nonetheless, several study limitations inherent to transversal design studies deserve mention. First, given the crosssectional design of this study, causality cannot be inferred with certainty. Second, hypertension and diabetes are agedependent diseases, so it is likely that some of the parents, currently healthy, will eventually develop HBP or diabetes; in the same way, given that CVRFs often present at a more advanced Tanner stage, it is probable that some children without current cardiovascular risk might develop the risk later in development. These possibilities introduce a potential source of selection bias due to misclassification of the groups as related to the exclusion criterion. Third, we have not collected data about possible confounders such as physical activity, diet pattern, serum uric acid, and magnesium levels. Fourth, the reference table for WC used is based on National Health and Nutrition Examination Survey (NHANES) data, so it is probable that these values do not entirely correspond to Mexican children; however, because not exist reference values for WC for Mexican children, we analyzed our data according the unique available reference. Lastly, sample size was estimated based upon previous data showing that HBP exhibited the lowest frequency amongst the CVRFs. Surprisingly, hyperglycemia showed a low prevalence in the current study; a finding probably related to the criterion for FPG used (FPG ≥110 mg/ dl). Thus, the sample size was not sufficiently large to provide statistical power to detect significant differences related to hyperglycemia. Strengths of our study include the sampling procedure for enrolling the prepubertal children and the classification of elevated WC and HBP based upon worldwide standard definitions. Furthermore, in order to minimize the influence of development stage and family history of diabetes on insulin levels, criteria were limited to children in Tanner stage 1 with negative family history of diabetes.
In conclusion, our data show that in the prepubertal children with nonelevated WC, FHH in the maternal branch is independently associated with CVRFs; this finding emphasizes the importance of parental history of hypertension in the implementation of public health strategies for preventing disease. 
